Schizophrenia: Overview and Treatment Options - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Heart failure is a common, costly, and debilitating syndrome that is associated with a highly
complex drug regimen, a large number of comorbidities, and a large and often disparate …

The lifespan of people with severe mental illness (SMI) is shorter compared to the general
population. This excess mortality is mainly due to physical illness. We report prevalence …

Physical disorders are, compared to the general population, more prevalent in people with
severe mental illness (SMI). Although this excess morbidity and mortality is largely due to …

Cardiovascular diseases are a leading cause of morbidity and mortality in most developed
countries of the world. Pharmaceuticals, illicit drugs, and toxins can significantly contribute to …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

Orthostatic hypotension (OH) is an abnormal blood pressure response to standing, which is
associated with an increased risk of adverse outcomes such as syncope, falls, cognitive …

In vitro model of the human cardiac tissues generated from human induced pluripotent stem
cells (hiPSCs) could facilitate drug discovery and patient-specific studies of physiology and …

This review discusses common mental health disorders and their associations with
cardiovascular disease risks. Commonly found mental health disorders include depression …

There is evidence that persistent psychiatric disorders lead to age-related disease and
premature mortality. Telomere length has emerged as a promising biomarker in studies that …